Oncovon
Oncovon Labs is a pioneering AI drug discovery company that aims to revolutionize the pharmaceutical industry by creating innovative tools and ecosystems. They offer an integrated, end-to-end solution for drug discovery, accelerating research across all stages. Their platform encompasses target identification, drug design, and synthesis planning, utilizing advanced technologies like AI, machine learning, deep learning, and graph neural networks. Oncovon Labs provides solutions for small molecules, peptides, and proteins, covering multi-omics analysis, systems and network biology, QSAR-like models, molecule design, virtual screening, molecule optimization, retrosynthetic analysis, and chemical catalogs. They also offer capabilities in compound synthesis, binding studies (SPR), cell-based validation, ADME screening, in-vitro tox profiling, and in-vivo efficacy studies. Their clinical trial solution, CLINVON, focuses on patient simulation and trial design using digital twins.
Oncovon
Oncovon Labs is a pioneering AI drug discovery company that aims to revolutionize the pharmaceutical industry by creating innovative tools and ecosystems. They offer an integrated, end-to-end solution for drug discovery, accelerating research across all stages. Their platform encompasses target identification, drug design, and synthesis planning, utilizing advanced technologies like AI, machine learning, deep learning, and graph neural networks. Oncovon Labs provides solutions for small molecules, peptides, and proteins, covering multi-omics analysis, systems and network biology, QSAR-like models, molecule design, virtual screening, molecule optimization, retrosynthetic analysis, and chemical catalogs. They also offer capabilities in compound synthesis, binding studies (SPR), cell-based validation, ADME screening, in-vitro tox profiling, and in-vivo efficacy studies. Their clinical trial solution, CLINVON, focuses on patient simulation and trial design using digital twins.